Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BLUE bluebird bio Inc
- Stocks
- Healthcare
- NASDAQ: BLUE
Price (delayed)
$4.97
Market cap
$48.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$20.42
Enterprise value
$157.85M
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer. The company's only - in the European Union -
Highlights
The revenue has surged by 128% year-on-year and by 24% since the previous quarter
The EPS has surged by 58% year-on-year and by 18% since the previous quarter
The quick ratio has plunged by 67% YoY but it has grown by 4% from the previous quarter
bluebird bio's equity has plunged by 144% YoY and by 84% from the previous quarter
Key stats
What are the main financial stats of BLUE
Market
Valuations
Earnings
Shares outstanding
9.79M
Market cap
$48.67M
Enterprise value
$157.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.52
Revenue
$103.95M
Gross profit
$28.19M
Operating income
-$216.38M
Net income
-$199.98M
EBIT
-$177.13M
EBITDA
-$92.84M
Free cash flow
-$230.47M
Per share
Balance sheet
Liquidity
EPS
-$20.42
EPS diluted
-$20.42
Free cash flow per share
-$23.64
Book value per share
-$5.91
Revenue per share
$10.66
TBVPS
$28.82
Total assets
$295.96M
Total liabilities
$353.82M
Debt
$187.93M
Equity
-$57.87M
Working capital
-$140.55M
Debt to equity
-3.25
Current ratio
0.55
Quick ratio
0.26
Net debt/EBITDA
-1.18
Margins
Efficiency
Dividend
EBITDA margin
-89.3%
Gross margin
27.1%
Net margin
-192.4%
Operating margin
-208.2%
Return on assets
-45.3%
Return on equity
N/A
Return on invested capital
-50%
Return on capital employed
N/A
Return on sales
-170.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BLUE stock price
How has the bluebird bio stock price performed over time
Intraday
0%
1 week
-0.4%
1 month
21.81%
1 year
-72.25%
YTD
-40.41%
QTD
1.84%
Financial performance
How have bluebird bio's revenue and profit performed over time
Revenue
$103.95M
Gross profit
$28.19M
Operating income
-$216.38M
Net income
-$199.98M
Gross margin
27.1%
Net margin
-192.4%
The revenue has surged by 128% year-on-year and by 24% since the previous quarter
bluebird bio's net margin has soared by 71% YoY and by 33% from the previous quarter
BLUE's operating margin has surged by 71% year-on-year and by 35% since the previous quarter
bluebird bio's operating income has increased by 35% YoY and by 20% from the previous quarter
Price vs fundamentals
How does BLUE's price correlate with its fundamentals
Growth
What is bluebird bio's growth rate over time
Valuation
What is bluebird bio stock price valuation
P/E
N/A
P/B
N/A
P/S
0.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.52
The EPS has surged by 58% year-on-year and by 18% since the previous quarter
bluebird bio's equity has plunged by 144% YoY and by 84% from the previous quarter
The revenue has surged by 128% year-on-year and by 24% since the previous quarter
BLUE's P/S is 99% below its 5-year quarterly average of 47.1 and 72% below its last 4 quarters average of 1.7
Efficiency
How efficient is bluebird bio business performance
The return on sales has surged by 73% year-on-year and by 35% since the previous quarter
bluebird bio's return on invested capital has decreased by 7% QoQ
bluebird bio's ROA has increased by 4.8% YoY
Dividends
What is BLUE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BLUE.
Financial health
How did bluebird bio financials performed over time
The total assets is 16% smaller than the total liabilities
The quick ratio has plunged by 67% YoY but it has grown by 4% from the previous quarter
The total assets has dropped by 53% year-on-year and by 36% since the previous quarter
bluebird bio's equity has plunged by 144% YoY and by 84% from the previous quarter
BLUE's debt to equity has surged by 71% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.